Unlock instant, AI-driven research and patent intelligence for your innovation.

Embryonic stem cell line and method for preparing the same

a stem cell line and embryonic technology, applied in the field of embryonic stem cell lines, can solve the problems of not being cultured, and no es cell line developed from human oocytes utilizing nuclear transfer technology

Inactive Publication Date: 2011-03-17
H BION
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention is about a new method for creating an embryonic stem cell (ES cell) line from a human oocyte. This is done by transferring the nucleus of a human somatic cell into an enucleated human oocyte and then fusing them. The resulting cell is then subjected to reprogramming, activation, and in vitro culturing to form a blastocyst. The blastocyst is then isolated and cultured to create the ES cell line. This method allows for the creation of a new ES cell line that can be used for various applications such as the development of nerve cells or neurological research."

Problems solved by technology

The cells isolated by Bongso et al. had a morphology expected in a pluripotent stem cell; however, they could not be cultured for a long-term period apparently because a proper feeder layer was not used.
Although several reports have indicated that an ES cell line can be established by employing a non-human mammalian oocyte, no ES cell line developed from a human oocyte utilizing the nuclear transfer technology has been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Embryonic stem cell line and method for preparing the same
  • Embryonic stem cell line and method for preparing the same
  • Embryonic stem cell line and method for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Oocyte and Nuclear Donor Cell

[0141]Voluntary oocyte donors were screened carefully through physical and mental examinations, and administered with follicle stimulation hormone (FSH) to induce superovulation.

[0142]About 36 hours after the administration of human chorionic gonadotropin (hCG) to the donors, cumulus-oocyte complexes (COCs) were recovered and cultured for 40 minutes in the G1.2 medium using an incubator maintained at 37° C., 5% CO2 and saturated humidity. Such COCs were treated with 0.1% (w / v) hyaluronidase (Sigma Co., St. Louis, Mo., U.S.A.) for 1 hour to disperse cumulus cells.

[0143]The oocytes were obtained by separating such cumulus cells from the COCs. The separated cumulus cells were isolated through a mouth pipette and washed with the G1.2 medium. Those cumulus cells having a modal diameter ranging from 10 to 12 mm were selected as nuclear donor cells.

example 2

Enucleation of Oocyte and Cell Fusion

[0144]One of the oocytes obtained in Example 1 was cultured in the G1.2 medium for 1 to 2 hours in order to induce the maturation of its nucleus. Thereafter, enucleation, nuclear transfer and electrofusion thereof were performed as follows.

[0145](2-1) Enucleation of Oocyte and Nuclear Transfer from Somatic Cell

[0146]The oocyte was washed once with the G1.2 medium. Such oocyte was transferred to a hyaluronidase solution prepared by mixing 1 ml of the G1.2 medium with 111 μl of a solution, wherein 0.05 g of hyaluronidase was dissolved in 5 ml of the G1.2 medium, and adjusted to a 0.1% (w / v) hyaluronidase concentration. The oocyte was stripped of any remaining cumulus cells, washed three times with the G1.2 medium and placed in the same medium. Then, the oocyte was transferred to a cytochalasin B solution prepared by mixing 1 ml of the G1.2 medium supplemented with 10% fetal bovine serum (FBS) with 1 μl of a solution wherein cytochalasin B was disso...

example 3

Reprogramming, Activation and In Vitro Culturing of Nucleus-Transferred Oocyte

[0155]Since a sperm-mediated activation, which is one of the major factors for a normal embryonic development, was absent in case of the nucleus-transferred oocyte obtained in Example 2, an artificial stimulus was needed instead. In order to determine the optimum conditions for artificial embryogenesis, therefore, nucleus-transferred oocytes were reprogrammed, activated and in vitro cultured under various conditions as shown in Tables 2 to 4.

[0156]First, to examine the effect of the reprogramming time on the rate of blastocyst formation, the reprogramming times were set at about 2, 4, 6 and 20 hours, respectively, while applying the same conditions for activation and in vitro culturing as can be seen from Table 2. As a result, the highest rate of blastocyst formation was obtained when the reprogramming time was about 2 hours.

TABLE 2No. of nucleus-transferred oocytesIn vitro culturedeveloped toReprogramming...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
time periodaaaaaaaaaa
time periodaaaaaaaaaa
time periodaaaaaaaaaa
Login to View More

Abstract

An embryonic stem cell line derived from a nucleus-transferred oocyte prepared by transferring a nucleus of a human somatic cell into an enucleated human oocyte may differentiate into various desired cell types.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is a continuation of U.S. patent application Ser. No. 10 / 584,255, filed on Jun. 28, 2007, which was a 35 U.S.C. §371 National Phase Entry Application from PCT / KR2004 / 003528, filed Dec. 30, 2004, and designating the United States, which claims priority under 35 U.S.C. §119 to PCT / KR03 / 002899 filed Dec. 30, 2003, which are incorporated herein in their entireties.FIELD OF THE INVENTION[0002]The present invention relates to an embryonic stem cell line and a method for preparing the same and, more particularly, to an embryonic stem cell line prepared by transferring a nucleus of a human somatic cell into an enucleated human oocyte, culturing the resulting nucleus-transferred oocyte to form a blastocyst, and culturing an inner cell mass isolated from the blastocyst, and a method for preparing the same.BACKGROUND OF THE INVENTION[0003]A stem cell is normally taken to mean an undifferentiated cell capable of differentiating into a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/63C12N5/10C12N5/00C12N5/0735C12N5/02C12N5/075C12N5/28C12N15/877
CPCC12N5/0606C12N15/8776C12N2500/25C12N15/87C12N2501/115C12N2501/235C12N2500/38C12N5/0619C12N15/877C12N2501/13C12N2500/40C12N2506/02C12N5/0623
Inventor ROH, SUNG-IIHWANG, WOO-SUKLEE, BYEONG-CHUNKANG, SUNG-KEUNRYU, YOUNG-JUNELEE, EU-GENEKIM, SOON-WOONGKWON, DAE-KEEKWON, HEE-SUNKOO, JA-MINPARK, EUL-SOONHWANG, YOUN-YOUNGYOON, HYUN-SOOPARK, JONG-HYUKKIM, SUN-JONG
Owner H BION